| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.356 | 3.626 | 2.503 | 4.209 | 4.800 | 7.867 |
| Total Income - EUR | - | - | - | - | 2.356 | 3.626 | 2.503 | 4.209 | 4.811 | 7.886 |
| Total Expenses - EUR | - | - | - | - | 256 | 184 | 138 | 371 | 468 | 498 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.100 | 3.442 | 2.364 | 3.838 | 4.343 | 7.388 |
| Net Profit/Loss - EUR | - | - | - | - | 2.029 | 3.289 | 2.290 | 3.734 | 3.753 | 6.265 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Edoscience S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 2.300 | 5.537 | 2.479 | 3.806 | 8.737 | 8.694 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 579 | 669 | 2.931 | 289 |
| Cash | - | - | - | - | 2.300 | 5.537 | 1.900 | 3.137 | 5.806 | 8.405 |
| Shareholders Funds | - | - | - | - | 2.071 | 3.331 | 2.331 | 3.775 | 7.516 | 8.604 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 229 | 2.207 | 149 | 32 | 1.222 | 90 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Edoscience S.r.l.